Abstract
The pathogenicity of Mycobacterium ulcerans (Buruli ulcer) is closely associated with the secretion of exotoxin mycolactone. The cytotoxicity of mycolactone has been linked to its apoptogenic activity. We explored if low mycolactone concentrations, which are not able to induce apoptosis, can influence other essential activities on two primary human keratinocyte populations, keratinocyte stem cells (KSC) and transit amplifying cells (TAC), and on a human keratinocyte line, HaCaT. We demonstrated that 0.01 and 0.1 ng/ml mycolactone A/B are not able to induce apoptosis in primary human keratinocytes, but interfere with KSC wound repair. Moreover, the same toxin concentrations reduce cell proliferation of KSC and TAC and their ability to adhere to type IV collagen. HaCaT cells are more resistant to the toxin; nevertheless, they show a delayed woud repair when treated with 1 and 10 ng/ml mycolactone A/B. Moreover, these sub-apoptotic concentrations affect their ability to proliferate and adhere to collagen IV. Wound healing is a complex mechanism, which occurs “in vivo” as the outcome of many co-ordinated events. Sub-apoptotic mycolactone concentrations can affect essential mechanisms, which are required to achieve wound repair, such as adhesion, migration and proliferation of human keratinocytes.
Similar content being viewed by others
References
Adusumilli S, Mve-Obiang A, Sparer T, Meyers W, Hayman J, Small PLC (2005) Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo. Cell Microbiol 7:1295–1304
Boleira M, Lupi O, Lehman L, Asiedu KB, Kiszewski AE (2010) Buruli ulcer. An Bras Dermatol 85:281–301
Boyer B, Tucker GC, Vallés AM, Franke WW, Thiery JP (1989) Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells. J Cell Biol 109:1495–1509
Bozzo C, Bellomo G, Silengo L, Tarone G, Altruda F (1997) Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions. Exp Cell Res 237:326–337
Bozzo C, Tiberio R, Graziola F, Pertusi G, Valente G, Colombo E et al (2010) A Mycobacterium ulcerans toxin, mycolactone, induces apoptosis in primary human keratinocytes and in HaCaT cells. Microbes Infect 12:1258–1263
Cadena-Herrera D, Esparza De Lara JE, Ramírez-Ibañez ND, López-Morales CA, Pérez N O, Flores-Ortiz LF, Medina-Rivero E (2015) Validation of three viable-cell counting methods: manual, semi-automated, and automated. Biotechnol Reports 7:9–16
Coutanceau E, Decalf J, Martino A, Babon A, Winter N, Cole ST et al (2007) Selective suppression of dendritic cell function by Mycobacterium ulcerans toxin mycolactone. J Exp Med 204:1395–1403
Coutanceau E, Marsollier L, Brosch R, Perret E, Goossens P, Tanguy M et al (2005) Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin. Cell Microbiol 7:1187–1196
Dobos KM, Small PL, Deslauriers M, Quinn FD, King CH (2001) Mycobacterium ulcerans citotoxicity in an adipose cell model. Infect Immun 69:7182–7186
George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, Lee R, Small PLC (1999) Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283:854–857
George KM, Pascopella L, Welty DM, Small PL (2000) A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun 68:877–883
Grönberg A, Zettergren L, Bergh K, Ståhle M, Heilborn J, Angeby K et al (2010) Antioxidants protect keratinocytes against M. ulcerans mycolactone cytotoxicity. Plos One 5:e13839
Gunawardana G, Chatterjee D, George KM, Brennan P, Whittern D, Small PLC (1999) Characterization of novel macrolide toxins, mycolactones A and B, from a human pathogen, Mycobacterium ulcerans. J Am Chem Soc 121:6092–6093
Johnson PD, Stinear T, Small PL, Pluschke G, Merritt RW, Portaels F, Huygen K, Hayman JA, Asiedu K (2005) Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PloS Med 2(4):e108
Jones PH, Watt FM (1993) Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73:713–724
Ogbechi J, Hall MT, Bodman BS, Smith K, Vogel M, Wu HL et al (2015) Mycolactone-dependent depletion of endothelial cell thrombomodulin is strongly associated with fibrin deposition in buruli ulcer lesions. PLoS Pathog 11(7):e1005011
Oliveira MS, Fraga AG, Torrado E, Castro AG, Pereira JP, Longatto Filho A et al (2005) Infection with Mycobacterium ulcerans induces persistent Inflammatory responses in mice. Infect Immun 73:6299–6310
Pertusi G, Tiberio R, Graziola F, Boggio P, Colombo E, Bozzo C (2012) Selective release of cytokines, chemokines, and growth factors by minced skin in vitro supports the effectiveness of autologous minced micrografts technique for chronic ulcer repair. Wound Repair Regen 20:178–184
Sarfo FS, Phillips RO, Rangers B, Mahrous EA, Lee RE, Tarelli E et al (2010) Detection of mycolactone A/B in Mycobacterium ulcerans-infected human tissue. PloS Negl Trop Dis 4:e577
Silva MT, Portaels F, Pedrosa J (2009) Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer. Lancet Infect Dis 9:699–710
Simmonds RE, Lali FV, Smallie T, Small PLC, Foxwell BM (2009) Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism. J Immunol 182:2194–2202
Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341:738–746
Tiberio R, Bozzo C, Pertusi G, Graziola F, Gattoni M, Griffanti, al P (2009) Calcipotriol induces apoptosis in psoriatic keratinocytes. Clin Exp Dermatol 34:e972–e974
van der Werf TS, Stinear T, Stienstra Y, van der Graf WTA, Small PL (2003) Mycolactones and Mycobacterium ulcerans disease. The Lancet 562:1062–1064
van der Werf TS, van der Graf WTA, Tappero JW, Asiedeu K (1999) Mycobacterium ulcerans infection. Lancet 354:1013–1018
Walsh DS, Meyers WM, Portaels F, Lane JE, Mongkolsirichaikul D, Hussem K et al (2005) High rates of apoptosis in human Mycobacterium ulcerans culture-positive Buruli Ulcer skin lesions. Am J trop Med Hyg 73:410–415
Zavattaro E, Boccafoschi F, Borgogna C, Conca A, Johnson RC, Sopoh GE et al (2012) Apoptosis in Buruli ulcer: a clinicopathological study of 45 cases. Histopathology 61:224–236
Zhivotovsky B, Nicotera P, Bellomo G, Hanson K, Orrenius S (1993) Ca2+ and endonuclease activation in radiation-induced lymphoid cell death. Exp Cell Res 207:163–170
Acknowledgements
We are grateful to Prof. Pamela Small (University of Tennessee, Knoxville) for providing natural mycolactone and to Prof. Enrico Colombo (Director of Dermatologic Clinic, Novara, Italy) for clinical support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
This work was partly supported by grant from University of Piemonte Orientale “A. Avogadro” to C.B.
Ethical approval
Skin specimens were collected from donors with their informed consent after the approval by ethical committee of the institute.
Rights and permissions
About this article
Cite this article
Graziola, F., Colombo, E., Tiberio, R. et al. Mycobacterium ulcerans mycolactone interferes with adhesion, migration and proliferation of primary human keratinocytes and HaCaT cell line. Arch Dermatol Res 309, 179–189 (2017). https://doi.org/10.1007/s00403-017-1719-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-017-1719-2